Researcher Explains How Women Respond to a False Positive Breast Cancer Screening Result
After a false positive outcome on screening mammography, a short interval call back for repeat imaging was a significant deterrent to future screening.
RSV Mortality Higher than for Influenza B After Hospital Discharge: Daily Dose
Your daily dose of the clinical news you may have missed.
Single vs Multiple Inhaler Triple Therapy for COPD Could Triple Adherence, Persistence: International Data
CHEST 2024: Combined data from 4 continents found consistently better adherence/persistence when COPD triple therapy was initiated with a single inhaler.
Remdesivir Plus Dexamethasone Reduces Mortality Risk among Adults Hospitalized with COVID-19
Remdesivir plus dexamethasone was associated with reduced 14- and 28-day mortality vs dexamethasone alone, according to a large study of adults hospitalized with COVID-19.
Early Identification, Treatment of COPD Reduces Exacerbations, Health Care Burden
CHEST 2024. Initial treatment for people with COPD should begin early in the disease and leads to significantly reduced risk for exacerbations and inpatient treatment.
Decrease in MHT Use over Past 2 Decades: Daily Dose
Obesity Management Demands Much More than Medication
Obesity is a complex disease that requires a multispecialty approach to address the physical and also the mental and emotional components of the widespread disorder.
The Potential Harms of Breast Cancer Screening Need to be Explored and this Biostatistician is All In
The most common harm associated with breast cancer screening is a false positive finding; this UC Davis expert wanted to know more about how women respond.
COVID-19 Linked to Long-Term Risk of MACE, Especially Among Adults with non-O Blood Types
Prior SARS-CoV-2 infection was associated with a 2-fold increased risk for MACE for up to 3 years, even among people with no history of CVD, in a new analysis of UK Biobank data.
Ensifentrine, Novel PDE3, PDE4 Inhibitor, Improves Lung Function, QoL Regardless of COPD Severity
The combined bronchodilator/anti-inflammatory agent significantly improved lung function, symptoms and QoL in adults with moderate or severe airflow obstruction.
Preconception Prediabetes in Young Women and Adverse Birth Outcomes: Daily Dose
FDA Black-Box Warnings on Antidepressants Linked to Reduced Treatment, Increased Risk of Suicide Among Youth
The FDA warnings were intended to increase physician monitoring for suicidal thoughts and behaviors but have had dramatic unintended consequences.
FDA Grants Marketing Authorization to First OTC Flu/COVID-19 Test Outside Emergency Use Declaration
The non-prescription test has more than 95% sensitivity and specificity for SARS-COV-2 and influenza A and B and delivers results in approximately 15 minutes.
FDA Approves First-Ever Biologic Medicine for COPD: Daily Dose
Menopausal VMS Education in Primary Care: Build Trust First, Says One Clinician
Building trust with patients early on will help them feel comfortable discussing their symptoms and treatment preferences, says JoAnn Pinkerton, MD.
Flu Vaccine Reduced Related Hospitalizations by About One-Third in Southern Hemisphere, but Uptake Still Low
Less than one-quarter of people infected with influenza-associated severe acute respiratory illness were vaccinated, according to a new report.
Menopausal Vasomotor Symptoms: Clinician and Patients Both Need Education, Expert Says
Less than 15% of women with menopause receive treatment for VMS, suggesting a need a for more education and awareness, according to JoAnn Pinkerton, MD.
Albuterol/Budesonide Reduces Risk of Exacerbation in People with Intermittent, Mild-Persistent Asthma
Albuterol/budesonide (Airsupra) has now proven effective as novel combination as-needed rescue medication for adults with asthma regardless of disease severity.
FDA Approves First-in-Class Schizophrenia Drug: Daily Dose
Dear Payers: Drugs for Early Alzheimer's Disease are ‘Worth It’
Medicare’s restrictive coverage policies are denying patients with early Alzheimer's disease access to novel treatments. And private payers are following suit.
